Identifying CEACAM1-targeted Drug Candidates for Cancer Immunotherapy
Year: 2024
Type: article
Abstract: Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is a key regulatory protein in immune modulation and tumor progression, making it a promising target for cancer immunotherapy. Immunotherapy is promising because it harnesses the body's own immune system to identify and eliminate cancer cells, o
Author: Guanrong Cheng
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W4404005516